The pharmaceutical company’s latest earnings exceeded Wall Street’s expectations as it braces for one of its top-selling ...
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/100.sbqKNnJW.js ...
HistoSonics, a medical device company backed by Johnson & Johnson’s venture capital arm, is exploring the possibility of a U.S. initial ...
Johnson & Johnson surpassed earnings expectations with strong sales, but it faces challenges ahead due to patent expirations.
In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on Johnson & Johnson (JNJ – Research Report), with a ...
Johnson & Johnson has a 12 month low of $140.68 and a 12 month high of $168.85. The company has a fifty day moving average price of $148.35 and a two-hundred day moving average price of $156.11.
The institutional investor owned 43,167 shares of the company’s stock after purchasing an additional 2,058 shares during the period. Johnson & Johnson makes up approximately 1.6% of Ellsworth ...
Racer on MSN13d
Johnson slated for only two Cup Series races this seasonJimmie Johnson will have a smaller NASCAR Cup Series schedule this season as he plans to compete in two of the sport’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback